Ordering the right guide for the job: what is sgrna in practice once design, chemistry and delivery are separated, when a synthetic guide beats an sgrna plasmid and when the plasmid is the only route, how sgrna libraries change the scale of everything downstream, why guide design has to be checked against the exact genome and cell line you will use rather than a reference, and what evidence proves a guide cut where it was meant to
A guide is a short sequence and almost everything that goes wrong with it happens before it is ordered. Designing against the wrong genome build, against a region that differs in your cell line, or in a format the delivery method cannot use accounts for most failed edits. This page is about the decisions that precede the order.
- good laboratory practice for nonclinical studies, 21 CFR
- Part 58
- the biosafety manual that decides containment for vector delivery
- BMBL
- electronic records and signatures, the clause behind an editing record
- Part 11
The figures in this panel are regulation and manual identifiers, named from the documents themselves and linked below. They are not prices: BioBricks publishes verified prices for synthesis services only, and does not imply a reagent price index it has not measured.
- 4 vendor service pages verifiedevery figure matched verbatim to the vendor's page
- Quoted and dated, never estimatedlast verification pass 2026-08-24
- 1 service classes coveredeach with measured search demand behind it
From design to a confirmed cut
- Design against the sequence you actually have. Cell lines carry variants, and a guide designed on a reference genome may sit across a polymorphism in your line. Sequence the target region in your own cells before ordering when the edit matters.
- Choose the format from the delivery route. Chemically synthesised guides suit ribonucleoprotein delivery and give a short exposure window. Plasmid or lentiviral expression suits stable systems, difficult cells and library work, and it integrates. The delivery route decides the format, not the other way round.
- Design several guides per target. Cutting efficiency varies widely and is not reliably predicted. Ordering three guides and testing them is faster and cheaper than optimising delivery around one that was never going to work.
- Plan the cutting assay before the experiment. A mismatch cleavage assay or amplicon sequencing of the target region tells you whether the guide worked, separately from whether the phenotype appeared. Without it, a null result is uninterpretable.
- Size a library screen honestly. Library work sets a representation requirement per guide that determines culture scale, transduction volume, sorting time and sequencing depth. Work those numbers before committing, because a screen below representation is noise.
- Store synthetic guides properly. Chemically modified guides are stable dried and much less so in solution. Aliquot on first dissolution, record the buffer and avoid repeated freezing and thawing.
Design tools rank, they do not predict
Scoring algorithms are useful for excluding obviously poor guides and for flagging off target risk, and they are weak at predicting which of several good candidates will cut well in your cells. Chromatin state, delivery and repair all intervene.
Treat the score as a filter and the bench as the test. Three guides screened empirically beats one guide chosen confidently.
What a library screen really costs
Representation is the constraint. Maintaining enough cells per guide at transduction, during selection, at sorting and at sequencing sets the scale of everything, and for larger libraries that scale is substantial in flasks, media and sequencing.
Calculate backwards from library size at the planning stage. Screens fail on representation far more often than on library quality.
Common questions
- Synthetic guide or expressed guide?
- Synthetic for transient editing, primary cells and lower off target exposure. Expressed for stable systems, for continuous selection pressure and for library screens. Both work; the delivery constraint usually decides.
- How many guides should be tested per target?
- At least three, screened for cutting before any phenotype work. Efficiency is poorly predicted by design tools, and testing is cheap compared with troubleshooting a delivery system that was never the problem.
- Does the guide need modification?
- Chemical modification at the ends improves stability and reduces innate immune sensing, which matters in primary cells. For robust cell lines with plasmid delivery it is unnecessary.
- How is cutting confirmed?
- Amplify the target region and sequence it deeply enough to see the indel spectrum, or run a mismatch cleavage assay for a quick estimate. Confirming at the locus is separate from confirming loss of the protein, and both are needed.
Get a shortlist for your project
Browse by service class
Sources
Cite or embed this figure
The median advertised gene synthesis price per base pair in the US research synthesis services market was $0.11 in August 2026, across 4 verified vendor service pages recorded in BioBricks Synthesis Price Index.
Cite as: "BioBricks Synthesis Price Index", updated 2026-08-24, https://biobricks.org/sgrna/.